Tag: Health care industry
-
The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame
The FDA’s investigation into the source of the cyclosporiasis outbreak is causing confusion as companies and consumers alike navigate new updates.
-
What to know about testosterone replacement therapy as the U.S. military plans to test troops
While some research has shown benefits for patients who qualify, questions remain about the therapy’s long-term risks and use among men without a medical need.
-
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly’s acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma’s embrace of a stigmatized class of medications for treating mental health.
-
Fat cat? Weight-loss drugs may be coming for your overweight pet
Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners spend more on animal health.
-
Trump rips Canada as wildfire smoke spreads, says U.S. will add pollution cost to tariffs
The smoke coming from active wildfires in Canada has led to unhealthy air quality in swaths of the U.S., which could affect the upcoming World Cup final.
-
The cyclosporiasis outbreak linked to Taco Bell is hitting some restaurant stocks, but don’t expect a long-term impact
Taco Bell, which the CDC linked to the cyclosporiasis outbreak, will likely recover soon from the health safety scare, according to analysts.
-
World’s largest olive oil company says market has ‘definitively’ entered new phase
The update comes as analysts raise concerns about the prospect of global olive oil supplies swinging dramatically from one season to the next.
-
Buy the contractor before the renovation is complete: This stock’s next growth phase is taking shape
The stock is trading near the low end of historical multiples despite improving fundamentals and catalysts ahead.
-
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
-
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into AI.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
